Abstract
The CDKN2A gene, which encodes the proteins p16INK4a and p14ARF, is located on chromosome 9p21. Germline mutations at this locus increase susceptibility to cutaneous malignant melanoma (CMM). In general, missense and nonsense mutations are primarily responsible for defective p16INK4a and possibly p14ARF protein function and account for ∼20% of inherited CMM cases. We report a G>T transversion mutation in the last nucleotide of exon 2, affecting the aspartic acid residue at position 153 of CDKN2A-p16INK4a in a proband with melanoma. If splicing were unaffected, this mutation would change Asp to Tyr. RT–PCR analysis, however, revealed that this mutation, which we have termed D153spl(c.457G>T), and a previously described mutation at the next nucleotide, IVS2+1G>T, result in identical aberrant splicing affecting both p16INK4a and p14ARF. The two main alternate splice products for each of the two normal transcripts includes a 74 bp deletion in exon 2, revealing a cryptic splice site, and the complete skipping of exon 2. The dual inactivation of p16INK4a and p14ARF may contribute to the CMM in these families.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Goldstein AM, Struewing JP, Chidambaram A, Fraser MC and Tucker MA . (2000). J. Natl. Cancer Inst., 92, 1006–1010.
Goldstein AM and Tucker MA . (2001). Arch. Dermatol., 137, 1493–1496.
Haber DA . (1997). Cell, 91, 555–558.
Harland M, Mistry S, Bishop DT and Bishop JA . (2001). Hum. Mol. Genet., 10, 2679–2686.
Hussussian CJ, Struewing JP, Goldstein AM, Higgins PA, Ally DS, Sheahan MD, Clark WJ, Tucker MA and Dracopoli NC . (1994). Nat. Genet., 8, 15–21.
Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day III RS, Johnson BE and Skolnick MH . (1994). Science, 264, 436–440.
Kefford RF, Newton Bishop JA, Bergman W and Tucker MA . (1999). J. Clin. Oncol., 17, 3245–3251.
Krawczak M, Reiss J and Cooper DN . (1992). Hum Genet, 90, 41–54.
Lynch HT, Brand RE, Hogg D, Deters CA, Fusaro RM, Lynch JF, Liu L, Knezetic J, Lassam NJ, Goggins M and Kern S . (2002). Cancer, 94, 84–96.
Moskaluk CA, Hruban H, Lietman A, Smyrk T, Fusaro L, Fusaro R, Lynch J, Yeo CJ, Jackson CE, Lynch HT and Kern SE . (1998). Hum. Mutat., 12, 70.
Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K and Carson DA . (1994). Nature, 368, 753–756.
Pesole G, Liuni S, Grillo G, Ippedico M, Larizza A, Makalowski W and Saccone C . (1999). Nucleic Acids Res., 27, 188–191.
Petronzelli F, Sollima D, Coppola G, Martini-Neri ME, Neri G and Genuardi M . (2001). Genes Chromosomes Cancer, 31, 398–401.
Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, Cordon-Cardo C and DePinho RA . (1998). Cell, 92, 713–723.
Quelle DE, Cheng M, Ashmun RA and Sherr CJ . (1997). Proc. Natl. Acad. Sci. USA, 94, 669–673.
Quelle DE, Zindy F, Ashmun RA and Sherr CJ . (1995). Cell, 83, 993–1000.
Rizos H, Becker TM, Holland EA, Kefford RF and Mann GJ . (1997). Oncogene, 15, 515–523.
Rocco JW and Sidransky D . (2001). Exp. Cell Res., 264, 42–55.
Serrano M, Hannon GJ and Beach D . (1993). Nature, 366, 704–707.
Zhang S, Ramsay ES and Mock BA . (1998). Proc. Natl. Acad. Sci. USA, 95, 2429–2434.
Zhang Y and Xiong Y . (1999). Mol. Cell, 3, 579–591.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is a ‘United States Government Work’ paper as defined by the US copyright Act
Rights and permissions
About this article
Cite this article
Rutter, J., Goldstein, A., Dávila, M. et al. CDKN2A point mutations D153spl(c.457G>T) and IVS2+1G>T result in aberrant splice products affecting both p16INK4a and p14ARF. Oncogene 22, 4444–4448 (2003). https://doi.org/10.1038/sj.onc.1206564
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206564
Keywords
This article is cited by
-
p16Ink4a overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors
Oncogene (2011)
-
Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling
European Journal of Human Genetics (2011)